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Abstract: Background
Coping strategies used by women with breast cancer are vital for adjustment to their
disease. Whilst it is clear that factors such as age at diagnosis, social support and
ethnicity can influence coping mechanisms, there is currently no information about
whether breast reconstruction changes mechanisms of coping for such patients. The
aims of this study, therefore, were to determine how women who have had immediate
breast reconstruction and mastectomy cope, compared to those who have mastectomy
alone, and whether there are differences in coping mechanisms due to breast
reconstruction surgery.
Methods
A retrospective cohort study, using a standardised questionnaire called the Brief Cope
Scale. Inclusion criteria: all women who had had immediate breast reconstruction and
mastectomy in Shropshire from 2003 to 2014 for ductal carcinoma in situ or node
negative invasive breast cancer.  Each patient was matched for year of diagnosis,
adjuvant therapy and age to one woman who had mastectomy alone.
Results
234 questionnaires were sent with a 58% response rate.  Significantly more patients
from the reconstruction cohort coped by active coping (T value 1.66, P value 0.04)
compared to those in the mastectomy alone cohort.  In contrast, significantly more
patients in the mastectomy alone cohort coped by active venting compared to the
reconstruction cohort (T value 1.71, P value 0.04).
Conclusion
This study indicates for the first time that breast reconstruction may alter coping
mechanisms in breast cancer survivors. Awareness of these coping mechanisms will
enable clinicians to provide appropriate, individualised support.
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Breast reconstruction effects coping 1 
mechanisms in breast cancer survivors 2 
Abstract  3 
Background Coping strategies used by women with breast cancer are vital for 4 
adjustment to their disease. Whilst it is clear that factors such as age at diagnosis, social 5 
support and ethnicity can influence coping mechanisms, there is currently no 6 
information about whether breast reconstruction changes mechanisms of coping for 7 
such patients. The aims of this study, therefore, were to determine how women who 8 
have had immediate breast reconstruction and mastectomy cope, compared to those who 9 
have mastectomy alone, and whether there are differences in coping mechanisms due to 10 
breast reconstruction surgery. 11 
Methods A retrospective cohort study, using a standardised questionnaire called the 12 
Brief Cope Scale. Inclusion criteria: all women who had had immediate breast 13 
reconstruction and mastectomy in Shropshire from 2003 to 2014 for ductal carcinoma in 14 
situ or node negative invasive breast cancer.  Each patient was matched for year of 15 
diagnosis, adjuvant therapy and age to one woman who had mastectomy alone. 16 
Results 234 questionnaires were sent with a 58% response rate.  Significantly more 17 
patients from the reconstruction cohort coped by active coping (T value 1.66, P value 18 
0.04) compared to those in the mastectomy alone cohort.  In contrast, significantly more 19 
patients in the mastectomy alone cohort coped by active venting compared to the 20 
reconstruction cohort (T value 1.71, P value 0.04).   21 
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Conclusion This study indicates for the first time that breast reconstruction may alter 22 
coping mechanisms in breast cancer survivors. Awareness of these coping mechanisms 23 
will enable clinicians to provide appropriate, individualised support. 24 
 25 
Keywords: Breast reconstruction; breast cancer; survivors; coping behaviour; defence 26 
mechanisms 27 
Abbreviations 28 
 BASO British Association Surgical Oncology 29 
 DCIS Ductal Carcinoma In Situ 30 
QOL Quality of life 31 
SATH Shrewsbury and Telford NHS Trust 32 
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Introduction 41 
Breast cancer is the most common malignancy of women with 1.67 million new cases 42 
diagnosed world-wide each year and is the most common cancer in the United Kingdom 43 
[1]. Worldwide Breast Cancer survivors are the largest group of cancer survivors 44 
accounting for 22% of an estimated 14.5 million cancer survivors [2]. In the UK there 45 
are over 500,000 people alive today who have, or have had, a diagnosis of breast cancer 46 
[3].  47 
“Coping” is a dynamic process of both thoughts and behaviour by which individuals 48 
manage the demand of stress. Coping mechanisms are an integral part of the cancer 49 
survivorship pathway and have been shown to affect many aspects of a patient’s health. 50 
Passive coping mechanisms such as avoidance have been shown to increase risk of 51 
anxiety and depression and are strongly related to negative health behaviours that affect 52 
diet, exercise, sleep and stress levels [4]. Similarly, maladaptive coping mechanisms 53 
such as denial, self-blame and venting have been positively related to physical and 54 
psychological distress levels [5]. In contrast, positive coping mechanisms such as 55 
positive reappraisal have been shown to be associated positively with patient’s well-56 
being [6].  Coping styles in breast cancer survivors have shown to be affected by many 57 
factors such as age at diagnosis, social support and ethnicity [7, 8, 9]. In particular, 58 
immediate breast reconstruction at the time of mastectomy with preservation of the 59 
breast form has been shown to be a positive influence on breast cancer patients [10]. 60 
This appears to affect both physical and emotional recovery [11], quality of life (QOL) 61 
[12] and psychosocial functioning [13].  62 
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There are currently no studies, however, to show whether immediate breast 64 
reconstruction at time of mastectomy compared to mastectomy alone changes coping 65 
mechanisms for breast cancer patients. The primary aim of this study, therefore, was to 66 
conduct a prospective cohort study to see how women who have had immediate breast 67 
reconstruction at time of mastectomy cope with breast cancer, compared to those who 68 
have mastectomy alone. The secondary aim was to see if there was a significant 69 
difference in coping styles due to breast reconstruction surgery. 70 
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Methods  85 
Ethics 86 
This cohort study had the full approval of the National Research Ethic Committee 87 
Wales REC4 Reference #14/WA/1174. 88 
 89 
Inclusion criteria 90 
The inclusion criteria for this study was all women who had had mastectomy with an 91 
immediate breast reconstruction in Shropshire between 2003 and 2014 for either ductal 92 
carcinoma in situ (DCIS) or invasive breast cancer which was node negative (invited 93 
group 1). The principle exclusion criteria were: men, node positive cancer and 94 
prophylactic mastectomy with breast reconstruction. Node positive cancer patients were 95 
excluded as there is evidence which shows that they have very different coping 96 
mechanisms because the cancer has spread and there is possibility of no cure. 97 
 98 
Study design 99 
Each index patient from invited group 1 was matched for year of diagnosis, adjuvant 100 
therapy and age to one woman who had mastectomy alone for DCIS or breast cancer 101 
which was node negative (invited group 2). If there was not a similar patient to match 102 
to, the nearest equivalent patient in age or adjuvant therapy was used.  Patients were 103 
identified using either British Association Surgical Oncology (BASO) or the Somerset 104 
Cancer Database.  105 
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A standardised questionnaire, the Brief Cope Scale [14], was sent to the two cohorts. 109 
This is an abbreviated version of the original Cope Inventory which was developed to 110 
reduce the time burden of the original protocol and also omitted scales that were found 111 
not to be important among breast cancer patients.  It is a 28 point item and is rated by a 112 
four-point Likert scale ranging from “I haven’t been doing this at all” (score one) to “I 113 
have been doing this a lot” (score four). The Brief Cope Scale covers 14 dimensions, 114 
with each dimension having two items.  115 
The questionnaire was anonymised and sent out with a detailed information sheet 116 
explaining the nature of the study. Participants, by returning the questionnaire, were 117 
implicitly consenting to be involved in the study. Patients identified by BASO system 118 
for inclusion in the study are termed invited groups 1&2 for reconstruction and 119 
mastectomy respectively.  Participants who responded are termed cohorts 1 &2 for 120 
reconstruction and mastectomy respectively.  Cohort demographics were assessed for 121 
comparability using Chi-squared analysis. Mean scores for each different coping style 122 
were calculated for each cohort and were compared using independent T-test analysis. 123 
Using a power calculation, the aim was to achieve a 56% response rate which would 124 
achieve a confidence level of 95% with a margin error of 5.5%. 125 
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Results 133 
Questionnaires were sent to a total of 234 patients: 117 in mastectomy and immediate 134 
reconstruction cohort (invited group 1), and 117 in mastectomy alone cohort (invited 135 
group 2). 136 
 137 
Demographics and clinical characteristics of study population 138 
The invited group’s demographics are summarised in Table 1. The mean age of the 139 
reconstruction group was 50, with a range of 29 to 70. The mean age of the mastectomy 140 
group was 52, with a range of 32 to 70. Invited groups were matched for both age and 141 
year of diagnosis. The reconstruction group had significantly more patients with DCIS 142 
47% (P= 0.0006) and good prognostic tumours 7% (P=0.009), compared to mastectomy 143 
group 25% and 1% respectively. The mastectomy group had significantly more patients 144 
that had adjuvant therapy 73% compared to mastectomy group 50% (P= 0.0002).  145 
 146 
Response rate and demographics of responders 147 
The response rate of the study was 58% (136 patients, with 77 responses from the 148 
reconstruction cohort 66% (Cohort 1) and 59 from the mastectomy cohort (Cohort 2) 149 
51%). This response rate was of sufficient power to achieve expected confidence level 150 
of 95% with a margin error of 5.5%.   151 
 152 
Demographics of responders are summarised in Table 2. The mean age of the 153 
reconstruction cohort was 52.4, with range 28-77, and the mean age of the mastectomy 154 
cohort was 53.3, with range 31 to 75. The majority of patients for both cohorts were 155 
White British or British/English.  156 
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Two thirds (i.e. 66%) of responders in the reconstruction cohort were supported (i.e. 157 
married or had a partner) and 72% of those in the mastectomy cohort were supported. 158 
The two cohorts of responders were similar in age, ethnicity and social support. 159 
 160 
Coping mechanisms 161 
The mean scores for each coping mechanism for the reconstruction cohort and the 162 
mastectomy alone cohort are presented in Table 3. For each of the fourteen coping 163 
dimensions there were two items “I haven’t been doing this at all” (score one) to “I have 164 
been doing this a lot” (score four), with range of scores from 2-8 for each coping style.  165 
Common coping mechanisms for the reconstruction cohort were acceptance, active 166 
coping and use of emotional support. Common coping mechanisms for the mastectomy 167 
cohort were acceptance, use of emotional support and positive reframing. Significantly 168 
more patients from the reconstruction cohort coped by active coping (T value 1.66 at P 169 
value 0.04).  Significantly less patients coped by active venting in the reconstruction 170 
cohort compared to the mastectomy cohort; (T value 1.71 at P value 0.04).  These 171 
results suggest that breast reconstruction has a positive effect on coping styles of breast 172 
cancer patients, allowing higher levels of active coping and lower levels of venting. 173 
 174 
Several factors, including age and social support, have been associated with differences 175 
in coping styles [4, 7, 8]. We were interested, therefore, to determine whether there are 176 
differences in coping styles between the mastectomy alone and the reconstruction 177 
cohort that relate to these two factors. When the data were analysed according to 178 
whether patients were supported or not, we found that significantly more patients in the 179 
supported group who had breast reconstruction coped by active coping compared to the 180 
mastectomy cohort (T value = 2.28 P = 0.01).  181 
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To assess whether age is related to any differences in coping styles, each cohort was 182 
split into two groups: a younger group (aged less than 49 years old) and an older group 183 
(aged more than 49 years old) (Table 4 and 5). Significantly more patients in the 184 
younger age group from the mastectomy cohort used either behavioural disengagement 185 
or emotional support as coping mechanisms (T value 1.86 at P value 0.03 and T value 186 
1.97 at P value 0.02, respectively), compared to the younger age group from the 187 
reconstruction cohort. Both of these coping styles are thought to represent types of 188 
maladaptive psycho-social adjustment [4, 5]. In the older age groups, significantly more 189 
patients in the reconstruction cohort used active coping than the mastectomy cohort (T 190 
value 1.88 at P value 0.03).  191 
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Discussion 203 
Both mastectomy and breast reconstruction have been shown to have individual effects 204 
on every aspect of a breast cancer survivors psychosocial adjustment from QOL to the 205 
ability of a patient to return to normal life [10, 11, 12, 13]. For the first time this study 206 
presents evidence to suggest that coping styles may be similarly affected. 207 
 208 
Common coping styles 209 
This study has shown that common coping mechanisms for both the immediate 210 
reconstruction cohort and the mastectomy alone cohort were acceptance and the use of 211 
emotional support. Similarly, a meta-analysis of 11,948 breast cancer patients found 212 
that acceptance (i.e. facing the reality even if it does not fit one’s expectations or 213 
desires, and the willingness to deal with this reality) was used as a primary coping 214 
mechanism and was associated with higher well-being and health [15]. 215 
 216 
Use of emotional support as a primary coping mechanism (i.e. talking to friends to 217 
discuss emotions and seeking moral support) also correlates with findings in the 218 
literature [16, 17]. This coping mechanism has been shown to be associated with better 219 
health status, and lower psychological distress [18].The other common coping 220 
mechanism within the mastectomy cohort was positive reframing. This coping style 221 
works to manage distressed emotions rather than dealing with the immediate stressor. 222 
Positive reframing has been shown to promote higher well-being and health [15].  223 
 224 
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The effect of breast reconstruction on coping mechanisms 227 
Within our study we found that a larger number of patients who had undergone 228 
immediate breast reconstruction coped by active coping (a positive coping style) and 229 
significantly less by venting (a negative coping style), compared to the mastectomy 230 
alone cohort. Venting, as an emotional coping strategy, results in focus on the distress 231 
that is being experienced and venting of feelings. Venting has been shown to be the 232 
greatest predictor of emotional distress [5] and has been shown to prevent adjustment to 233 
diagnosis with increased levels of anxiety and depression [19]. Active coping strategies 234 
involve an awareness of the stressor, followed by attempts to reduce any associated 235 
negative outcome, and have been shown to improve QOL and well-being in all types of 236 
cancer survivors including breast [20], ovarian [21] and prostate cancer [22]. It is also 237 
an important form of coping in other forms of reconstruction, such as for total nasal 238 
defects following radical tumour resection [23] and skin graft reconstruction for severe 239 
burns injury [24]. It is not unsurprising, therefore, that this is the predominant coping 240 
style within the reconstruction cohort, as breast reconstruction reduces the impact of the 241 
loss of breast form and associated effects on the patient’s identity. This reinforces the 242 
importance of this study by highlighting how individual treatments can alter coping 243 
mechanisms of the patient. 244 
 245 
 246 
 247 
 248 
 249 
 250 
 251 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
Age differences and coping mechanisms 252 
 The results from this study indicate that common coping mechanisms in the younger 253 
responders from the mastectomy alone cohort are behavioural disengagement and the 254 
use of emotional support. It has been shown previously those patients who survive 255 
cancer at a younger age struggle more with their diagnosis due to the implications on 256 
life goals and subsequent roles in life [7].  257 
 258 
Behavioural disengagement is a form of avoidance where the participant withdraws or 259 
does not engage in any actions in order to cope. Thus, young women who are diagnosed 260 
with breast cancer and need a mastectomy struggle to cope and do so by disengagement. 261 
This type of coping has been shown to be consistently associated with poor adjustment 262 
to cancer diagnosis [15]. 263 
 264 
The other common coping style of the younger mastectomy cohort was the use of 265 
emotional support. This is a common coping style in breast cancer survivors and has 266 
been shown to be predicted by uncertainty in illness [16, 17]. This finding would 267 
certainly fit with our study as there is a recognised increase in uncertainty for patients 268 
diagnosed at younger age with changing life goals and roles. In contrast, older patients 269 
in our study commonly coped by active coping. Older patients are thought more likely 270 
to anticipate the onset of chronic illness in their advancing years and they are more 271 
likely to have achieved life goals. Thus, as concluded by Costanzo (2009, p.147), “age 272 
appeared to confer resiliency; older survivors were more likely than younger adults to 273 
show psychosocial functioning”. 274 
 275 
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Social support and coping mechanisms 277 
Supported patients (e.g. those married or living with a partner) in the reconstruction 278 
cohort also coped more by active coping. Social support has been shown to be an 279 
important factor in determining coping styles. For example, emotional support in the 280 
form of husband/wife, partner, or friends has been shown to have the strongest 281 
relationship with positive coping styles such as active coping [8].  This is also supported 282 
by a study that showed that cancer survivors who have perceived high levels of social 283 
support tend to choose active coping strategies and have more positive changes in their 284 
health behaviours [4]. 285 
 286 
Potential limitations  287 
It has been shown that scores on coping with cancer can vary over time [25]. A 288 
limitation of the current study, therefore, is that it included patients diagnosed over an 289 
eleven year period. Though patients were matched for year of diagnosis it is possible 290 
that they may have not responded to questions on how they coped at the time of 291 
diagnosis but how they are coping currently. In the future, it will be important to 292 
compare coping at more than one time interval point, to look at the stability of coping 293 
mechanisms over time.  294 
 295 
Non-responder bias is another potential limitation in questionnaire cohort research. It 296 
may be, for example, that the non-responders were struggling to cope and felt unable or 297 
unwilling to respond, and so we may have missed an important finding.  Due to the 298 
anonymity of responders, we cannot delineate the demographics of the non-responders, 299 
apart from acknowledging a higher non response rate in the mastectomy cohort than the 300 
reconstruction cohort, with 50% and 35% respectively. 301 
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 In particular, we do not know the tumour type the responders have as this was not 302 
included within the questionnaire. However, as reasoned above, this research study was 303 
sufficiently powered and thus we can be confident that we have a representative 304 
response from each cohort. 305 
 306 
 In this research study there was significant variability between the two invited groups 307 
and tumour types (Table 1), in that more patients in the reconstruction cohort had DCIS 308 
than invasive breast cancer. One of the main reasons for this is that better prognosis 309 
tumours are less likely to need adjuvant therapy such as chemotherapy and these 310 
patients are more likely to be considered suitable for breast reconstruction. This is an 311 
expected difference as patients who have mastectomy for DCIS usually don’t need 312 
adjuvant therapy such as radiotherapy and thus are very suitable candidates for 313 
reconstruction. Similarly, those less common tumours such as papillary and tubular 314 
which have better prognosis were more common in the reconstruction cohort. 315 
Subsequently, significantly more patients in the mastectomy cohort had ductal 316 
carcinoma and lobular carcinoma. Other published research shows similar variability 317 
between surgical groups [26, 27]. 318 
 319 
In our study the mastectomy cohort had significantly more patients who had 320 
chemotherapy and this is because patients and surgeons may choose to opt for 321 
mastectomy alone if adjuvant therapy will be required to make sure recovery for breast 322 
reconstruction does not delay this therapy. Indeed, not having neo-adjuvant treatment   323 
has been shown to be a predictor of immediate breast reconstruction [28].   324 
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Though chemotherapy has been shown to effect coping styles [29], there is growing 327 
evidence that this only occurs in a third of cancer survivors with many patients having 328 
cognitive deficits following surgery prior to starting any adjuvant therapy [30]. Thus, 329 
we have reason to explain the variability within our cohorts and in context with the 330 
evidence of the literature it may not necessarily represent a confounding factor to our 331 
results. 332 
 333 
Future research 334 
Though the work presented here has shed some light on coping mechanisms in breast 335 
cancer survivors, there is much scope for future work on this important research topic. 336 
To increase the generalisability of the results, a large multi-centre prospective cohort 337 
study of breast cancer patients with immediate reconstruction and mastectomy or 338 
mastectomy alone should be conducted to include representation from both urban and 339 
rural populations.  By capturing a wider range of demographic data such as age, 340 
ethnicity, social support (marital status and social network), religion, socio-341 
demographic characteristics: education level, family income, tumour type, and adjuvant 342 
therapy; chemotherapy, radiotherapy, Herceptin or hormone therapy, a more detailed  343 
analysis could be conducted to gain further insights into the complex issues that may 344 
influence coping mechanisms. It would also be important to look at whether reasons 345 
that might preclude breast reconstruction such as existing co-morbidities and if surgical 346 
outcome from reconstruction also have influence. In addition, quality of life measures, 347 
along with data from anxiety and depression scales could potentially highlight any 348 
neuropsychological deficits related to coping styles. The stability of coping mechanisms 349 
could be determined by longitudinal analysis of Brief Cope Scale data at (for example), 350 
time of diagnosis, twelve months and five years.  351 
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Conclusion 352 
This study presents the first evidence to suggest that breast reconstruction alters coping 353 
mechanisms and styles in breast cancer patients. In particular, breast reconstruction 354 
appears to alter coping mechanisms in breast cancer survivors by allowing less venting 355 
coping style and more active coping. Older patients and those with social support cope 356 
with more positive coping styles such as active coping, while younger patients tended to 357 
struggle and cope with maladaptive styles such as behavioural disengagement. 358 
Understanding how breast surgery, in particular breast reconstruction, changes coping 359 
mechanisms will allow clinicians to understand cancer survivorship in breast cancer 360 
patients and helps to inform individualised care plans and needed support. Further 361 
research is needed on this important issue. 362 
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Table 1 Demographics of invited groups 
 Reconstruction invited  
group 
Mastectomy invited 
group 
Statistic 
    
Age 50.2 (range 29-66) 51.7 (range 32-70) T value 1.39 P=0.08 
Year of Diagnosis    
                2003 
                2004 
                2005 
                2006 
                2007 
                2008 
                2009 
                2010 
                2011 
                2012 
                2013 
                2014 
 
5 
3 
4 
4 
4 
3 
13 
13 
21 
14 
16 
17 
5 
3 
4 
4 
4 
3 
13 
13 
21 
14 
18 
15* 
 
 
Pathology 
DCIS 
Ductal cancer 
Lobular cancer 
Other  
 
 
55 
45 
8 
9 
 
30 
67 
19 
1 
 
χ²=11.6 P= 0.0006 
χ² =8.29 P=0.004 
χ² =5.07 P=0.02 
χ² =6.69 P=0.009 
Adjuvant therapy    
None 
Hormone therapy  
Hormone therapy        
and radiotherapy 
Chemotherapy and 
other adjuvant 
therapy 
   59 
   30 
    4 
 
    24 
   31 
   30 
   13 
 
   43 
χ² =14.2 P= 0.0002 
χ² =0 P=1 
χ² =5.14 P=0.02 
 
χ² =7.55 P=0.006 
    
Total 117 117  
Significant results at P<0.05 Highlighted in purple 
*No suitable patients in 2014 to match so two extra patients from 2013 included 
** Other (Adenocarcinoma, Medullary, Papillary, Tubular) 
 
 
 
 
 
 
Table
Table 2 Demographics of responders 
 Reconstruction 
cohort (Cohort 1) 
Mastectomy cohort 
(Cohort 2) 
Statistic 
    
Age 52.4 (range 28-77) 53.3 (range 31-75) T value 0.44 P =0.32 
Ethnic group 
            White British                                                 
            British/English 
            Black Caribbean   
            Chinese 
            White European  
            Not recorded 
   
 
55
12 
2 
1 
1 
6 
 
 
46 
11 
0 
0 
0 
2 
 
 
 
 
 
 
 
Marital Status 
           Unsupported 
           Single 
           Divorced 
           Widowed 
           Supported 
           Married 
 
24 
6 
15 
3 
51 
45 
 
17 
7 
8 
2 
42 
36 
 
χ² =0.024 P0.877 
 
           Partner 
           Not recorded 
6 
2 
6 
0 
 
Total 77 59  
 
Table 3 Mean scores for coping styles of responders 
Coping Style Reconstruction 
cohort 
Mastectomy cohort Statistic 
    
Self-distraction 
Active coping 
4.83 
5.49 
4.81 
4.90 
T value 0.05 p=0.48 
T value 1.88 P<0.04 
Denial 3.12 3.29 T value 0.57 p=0.25 
Substance use 2.79 2.81 T value 0.09 P=0.46 
Use of emotional  
support 
Use of instrumental 
support 
5.21 
 
4.16 
5.26 
 
4.33 
T value 0.13 p=0.45 
 
T value 0.51 p=0.30 
Behavioural 
disengagement 
Venting 
Positive reframing 
Planning 
Humor 
Acceptance 
Religion 
Self-blame 
2.63 
 
3.29 
4.96 
4.65 
4.56 
6.72 
3.01 
3.51 
2.74 
 
3.79 
5.00 
4.88 
4.93 
6.84 
3.00 
3.16 
T value 0.53 P=0.30 
 
T value 1.71 p<0.04 
T value 0.64 P=0.26 
T value 0.97 p=0.16 
T value 0.03 P=0.49 
T value 0.03 P=0.49 
T value 0.04 p=0.48 
T value 1.16 P=0.12 
    
Significant results at P<0.05 Highlighted in purple 
 
 
Table 4 Means scores for Coping styles in younger age group <49 
Coping Style Reconstruction 
cohort 
Mastectomy cohort Statistic 
Self-distraction 
Active coping 
Denial 
Substance use 
Use of emotional  
support 
Use of instrumental 
support 
Behavioural 
disengagement 
Venting 
Positive reframing 
Planning 
Humor 
Acceptance 
Religion 
Self-blame 
5.17 
5.39 
3.22 
3.04 
4.57 
 
3.91 
 
2.52 
 
3.65 
5.35 
4.57 
4.91 
6.26 
2.74 
3.91 
5.81 
5.38 
3.13 
2.75 
5.75 
 
4.75 
 
3.38 
 
4.19 
5.19 
4.93 
5.06 
7.06 
3.13 
3.44 
 
T value 1.13 p=0.13 
T value 0.03 p=0.49 
T value 0.19 p=0.43 
T value 0.58 p=0.28 
T value 1.97 p<0.02 
 
T value 1.37 p=0.09 
 
T value 1.86 p<0.03 
 
T value 0.94 p=0.18 
T value 0.25 p=0.40 
T value 0.68 p=0.25 
T value 0.20 P=0.42 
T value 1.48 P=0.07 
T value 0.78 P=0.22 
T value 0.73 P=0.23 
Significant results at P<0.05 Highlighted in purple 
 
Table 5 Mean scores for Coping Styles in older age group 49 or older 
Coping style Reconstruction 
cohort 
Mastectomy cohort Statistic 
    
Self-distraction 
Active coping 
Denial 
Substance use 
Use of emotional  
support 
Use of instrumental 
support 
Behavioural 
disengagement 
Venting 
Positive reframing 
Planning 
Humor 
Acceptance 
Religion 
Self-blame  
4.67 
5.54 
3.08 
2.67 
5.5 
 
4.27 
 
2.67 
 
3.13 
4.79 
4.69 
4.4 
6.92 
3.13 
3.33 
4.43 
4.71 
3.36 
2.83 
5.07 
 
4.17 
 
2.5 
 
3.64 
4.93 
4.86 
4.88 
6.76 
2.95 
3.05 
 
T value 0.60 P=0.27 
T value 1.88 P<0.03 
T value 0.74 P=0.23 
T value 0.50 p=0.31 
T value 1.02 P=0.16 
 
T value 0.27 P=0.40 
 
T value 0.73 P=0.23 
 
T value 1.51 P=0.07 
T value 0.32 P=0.37 
T value 0.39 P=0.36 
T value 1.07 P=0.14 
T value 0.49 P=0.31 
T value 0.51 P=0.30 
T value 0.84 P=0.21 
Significant results at P<0.05 Highlighted in purple 
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